Lidocaine 5% Topical Anorectal Cream

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	73715-002		I	Inactivated by FDA		2026-10-05
excluded package	package	73715-002	73715-002-01	I	Inactivated by FDA		2026-10-05

Adverse event summaries are temporarily unavailable. Other product information remains available.

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73715-002-01	Lidocaine 5% Topical Anorectal Cream	30 g in 1 TUBE	CREAM	30		5

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73715-002	LIDOCAINE 5% TOPICAL ANORECTAL CREAM CREAM [MOHNARK PHARMACEUTICALS INC.]	5	Legacy NDC, 1 package rows	20250515_a7205326-18dc-2ebb-e053-2995a90a8312.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98PI200987	LIDOCAINE	137-58-6	LIDOCAINE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
73715-002-01	73715000201	30 g in 1 TUBE (73715-002-01)	30 g	2020-06-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lidocaine 5% Topical Anorectal Cream	Mohnark Pharmaceuticals Inc.	2025-05-13	HUMAN OTC DRUG LABEL	5